BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24845563)

  • 1. Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.
    Wu Z; Cui F; Yu F; Peng X; Jiang T; Chen D; Lu S; Tang H; Peng Z
    Biochem Biophys Res Commun; 2014 Jun; 449(2):208-15. PubMed ID: 24845563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.
    Xia D; Yang X; Liu W; Shen F; Pan J; Lin Y; Du N; Sun Y; Xi X
    Biochem Biophys Res Commun; 2017 Apr; 486(1):191-197. PubMed ID: 28286267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma.
    Xu M; Jia Y; Liu Z; Ding L; Tian R; Gu H; Wang Y; Zhang H; Tu K; Liu Q
    Onco Targets Ther; 2016; 9():4023-35. PubMed ID: 27445493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
    Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
    Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
    Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer.
    Jiang T; Yang C; Ma L; Wu Z; Ye L; Ma X; Li H; Fan J; Yang Y
    Dis Markers; 2017; 2017():1202710. PubMed ID: 29445249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression.
    Zheng L; Liang X; Li S; Li T; Shang W; Ma L; Jia X; Shao W; Sun P; Chen C; Jia J
    EBioMedicine; 2018 Dec; 38():69-78. PubMed ID: 30449701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
    Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of CHAF1A promotes cell proliferation and apoptosis resistance in glioblastoma cells via AKT/FOXO3a/Bim pathway.
    Peng H; Du B; Jiang H; Gao J
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1111-6. PubMed ID: 26740175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.
    Barbieri E; De Preter K; Capasso M; Chen Z; Hsu DM; Tonini GP; Lefever S; Hicks J; Versteeg R; Pession A; Speleman F; Kim ES; Shohet JM
    Cancer Res; 2014 Feb; 74(3):765-74. PubMed ID: 24335960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a.
    Hu CE; Liu YC; Zhang HD; Huang GJ
    Biochem Biophys Res Commun; 2014 Jun; 448(4):437-42. PubMed ID: 24796666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
    Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
    Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
    Yan W; Shi X; Wang H; Liao A; Yang W
    J Transl Med; 2022 Jun; 20(1):296. PubMed ID: 35773729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
    Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
    J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.
    Li D; Sun X; Yan D; Huang J; Luo Q; Tang H; Peng Z
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1231-40. PubMed ID: 23104504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone chaperone CHAF1A impacts the outcome of fluoropyrimidines-based adjuvant therapy in gastric cancer by regulating the expression of thymidylate synthetase.
    Wang D; Li X; Shen B; Chen X; Shu Y
    Gene; 2019 Oct; 716():144034. PubMed ID: 31377317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.